An algorithm to identify medication nonpersistence using electronic pharmacy databases

OBJECTIVE Identifying patients who are medication nonpersistent (fail to refill in a timely manner) is important for healthcare operations and research. However, consistent methods to detect nonpersistence using electronic pharmacy records are presently lacking. We developed and validated a nonpersistence algorithm for chronically used medications. MATERIALS AND METHODS Refill patterns of adult diabetes patients (n = 14,349) prescribed cardiometabolic therapies were studied. We evaluated various grace periods (30-300 days) to identify medication nonpersistence, which is defined as a gap between refills that exceeds a threshold equal to the last days' supply dispensed plus a grace period plus days of stockpiled medication. Since data on medication stockpiles are typically unavailable for ongoing users, we compared nonpersistence to rates calculated using algorithms that ignored stockpiles. RESULTS When using grace periods equal to or greater than the number of days' supply dispensed (i.e., at least 100 days), this novel algorithm for medication nonpersistence gave consistent results whether or not it accounted for days of stockpiled medication. The agreement (Kappa coefficients) between nonpersistence rates using algorithms with versus without stockpiling improved with longer grace periods and ranged from 0.63 (for 30 days) to 0.98 (for a 300-day grace period). CONCLUSIONS Our method has utility for health care operations and research in prevalent (ongoing) and new user cohorts. The algorithm detects a subset of patients with inadequate medication-taking behavior not identified as primary nonadherent or secondary nonadherent. Healthcare systems can most comprehensively identify patients with short- or long-term medication underutilization by identifying primary nonadherence, secondary nonadherence, and nonpersistence.

[1]  K. Chan,et al.  Methods for evaluation of medication adherence and persistence using automated databases , 2006, Pharmacoepidemiology and drug safety.

[2]  Rishi Sikka,et al.  Estimating medication persistency using administrative claims data. , 2005, The American journal of managed care.

[3]  N. Krieger Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.

[4]  P Michael Ho,et al.  Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. , 2008, American heart journal.

[5]  C. Rand,et al.  Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. , 1999, Medical care.

[6]  M. Sevick,et al.  Medication nonadherence: a diagnosable and treatable medical condition. , 2013, JAMA.

[7]  David L McClure,et al.  Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease , 2006, BMC cardiovascular disorders.

[8]  Romain Neugebauer,et al.  Cohort Profile: The Diabetes Study of Northern California (DISTANCE)--objectives and design of a survey follow-up study of social health disparities in a managed care population. , 2009, International journal of epidemiology.

[9]  N. Keiding,et al.  Validation of methods for identifying discontinuation of treatment from prescription data , 2010 .

[10]  Jennifer Y. Liu,et al.  Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. , 2001, The American journal of medicine.

[11]  J. Liberman,et al.  Recent trends in the dispensing of 90-day-supply prescriptions at retail pharmacies: implications for improved convenience and access. , 2011, American health & drug benefits.

[12]  Harlan M Krumholz,et al.  Impact of medication therapy discontinuation on mortality after myocardial infarction. , 2006, Archives of internal medicine.

[13]  M. Abrahamowicz,et al.  Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study , 2011, Annals of the rheumatic diseases.

[14]  Anuja Roy,et al.  Medication compliance and persistence: terminology and definitions. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[15]  Yongfei Wang,et al.  Discontinuation of Antihyperglycemic Therapy and Clinical Outcomes After Acute Myocardial Infarction in Older Patients With Diabetes , 2010, Circulation. Cardiovascular quality and outcomes.

[16]  M Alan Brookhart,et al.  Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. , 2007, Archives of internal medicine.

[17]  T D Koepsell,et al.  A General Method of Compliance Assessment Using Centralized Pharmacy Records: Description and Validation , 1988, Medical care.

[18]  J. Steiner,et al.  Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic Databases , 2013, Medical care.

[19]  Melissa M. Parker,et al.  New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. , 2009, Health services research.

[20]  S. Morgan,et al.  Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization. , 2006, Clinical therapeutics.

[21]  R. Marshall,et al.  Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2) , 2014, Heart.

[22]  M. Taitel,et al.  Medication days' supply, adherence, wastage, and cost among chronic patients in Medicaid. , 2012, Medicare & medicaid research review.

[23]  Amy M. Bauer,et al.  Associations Between Antidepressant Adherence and Shared Decision-Making, Patient–Provider Trust, and Communication Among Adults with Diabetes: Diabetes Study of Northern California (DISTANCE) , 2014, Journal of General Internal Medicine.

[24]  A. de Boer,et al.  Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. , 2006, Journal of clinical epidemiology.

[25]  H. S. Lau,et al.  Validation of pharmacy records in drug exposure assessment. , 1997, Journal of clinical epidemiology.

[26]  Niels Keiding,et al.  Estimating the effect of current, previous and never use of drugs in studies based on prescription registries , 2009, Pharmacoepidemiology and drug safety.

[27]  K. Olson,et al.  Out-of-plan pharmacy use by members of a managed care organization. , 2012, The Permanente journal.

[28]  D. Alter,et al.  Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. , 2007, JAMA.

[29]  R. Hiatt,et al.  Characteristics of patients referred for treatment of end-stage renal disease in a defined population. , 1982, American journal of public health.

[30]  M. Hudson,et al.  Comparison of measures of medication persistency using a prescription drug database. , 2007, American heart journal.

[31]  Melissa M. Parker,et al.  Glycemic response to newly initiated diabetes therapies. , 2007, The American journal of managed care.

[32]  S. Johansson,et al.  Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care , 2011, BMJ : British Medical Journal.

[33]  S. Erickson,et al.  The Concordance of Self-Report With Other Measures of Medication Adherence: A Summary of the Literature , 2004, Medical care.